California Institute for Biomedical Research:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:California Institute for Biomedical Research - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9432
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
California Institute for Biomedical Research (Calibr) is a not for profit organization that offers translational research. The organization discovers and develops therapies for unmet medical needs. It conducts research in the human disease areas of degenerative and age-related diseases, cancer, spinal muscular atrophy, cystic fibrosis, diarheal disease, HIV, and tuberculosis, childhood leukemia, metabolic and cardiovascular diseases, autoimmune and inflammatory diseases among others. It conducts research on a wide range of disease areas to produce paradigm-changing medicines. Calibr is headquartered in La Jolla, California, the US.

California Institute for Biomedical Research – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
California Institute for Biomedical Research, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
California Institute for Biomedical Research, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
California Institute for Biomedical Research, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
California Institute for Biomedical Research, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
California Institute for Biomedical Research, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
California Institute for Biomedical Research, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Ark Biosciences Enters into Co-Development Agreement with California Institute for Biomedical Research 10
HitGen Enters into Partnership with Scripps Research Institute and California Institute for Biomedical Research 11
Sirenas to Enter into Agreement with California Institute for Biomedical Research 12
Pfizer Enters into Agreement with California Institute for Biomedical Research 13
Cure SMA Enters into Research Agreement with California Institute for Biomedical Research 14
Licensing Agreements 15
AbbVie to Enter into Licensing Agreement with California Institute for Biomedical Research 15
Intarcia Therapeutics Enters into Licensing Agreement with California Institute for Biomedical Research 16
Bristol-Myers Squibb Enters into Licensing Agreement with California Institute for Biomedical Research 17
California Institute for Biomedical Research – Key Competitors 18
California Institute for Biomedical Research – Key Employees 19
California Institute for Biomedical Research – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Product News 21
03/14/2018: Calibr’s repurposed drug to treat non-viral diarrhea enters into a clinical trial 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
California Institute for Biomedical Research, Pharmaceuticals & Healthcare, Key Facts 2
California Institute for Biomedical Research, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
California Institute for Biomedical Research, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
California Institute for Biomedical Research, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
California Institute for Biomedical Research, Deals By Therapy Area, 2012 to YTD 2018 8
California Institute for Biomedical Research, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Ark Biosciences Enters into Co-Development Agreement with California Institute for Biomedical Research 10
HitGen Enters into Partnership with Scripps Research Institute and California Institute for Biomedical Research 11
Sirenas to Enter into Agreement with California Institute for Biomedical Research 12
Pfizer Enters into Agreement with California Institute for Biomedical Research 13
Cure SMA Enters into Research Agreement with California Institute for Biomedical Research 14
AbbVie to Enter into Licensing Agreement with California Institute for Biomedical Research 15
Intarcia Therapeutics Enters into Licensing Agreement with California Institute for Biomedical Research 16
Bristol-Myers Squibb Enters into Licensing Agreement with California Institute for Biomedical Research 17
California Institute for Biomedical Research, Key Competitors 18
California Institute for Biomedical Research, Key Employees 19

List of Figures
California Institute for Biomedical Research, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
California Institute for Biomedical Research, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
California Institute for Biomedical Research, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
California Institute for Biomedical Research, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
California Institute for Biomedical Research, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
California Institute for Biomedical Research, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
California Institute for Biomedical Research, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
California Institute for Biomedical Research, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[California Institute for Biomedical Research:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Panther Energy Company LLC:石油・ガス:M&Aディール及び事業提携情報
    Summary Panther Energy Company LLC (PEC) is an oil and gas company that offers drilling services. The company’s business activities include exploration, acquisition, development and production of oil, natural gas liquids and natural gas. It carries out grassroots horizontal exploration of unconventi …
  • Fujisoft Inc (9749):企業の財務・戦略的SWOT分析
    Fujisoft Inc (9749) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • MDNA Life Sciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary MDNA Life Sciences Inc (MDNA) is a molecular diagnostics company that develops molecular tests based on the mitochondrial genome. The company’s prostate core mitomic test is based on the science of mitochondrial DNA, a tissue-based prostate cancer diagnostics for prostate and other cancers. …
  • NorthWestern Corporation (NWE):電力:M&Aディール及び事業提携情報
    Summary NorthWestern Corporation, doing business as NorthWestern Energy, is an electric and natural gas utility. It generates, transmits, and electricity, and also carries out mid-stream operations. The company produces from wind, hydro, solar, coal, and natural gas. NorthWestern Energy produces, st …
  • Franklin Resources, Inc.:企業の戦略・SWOT・財務情報
    Franklin Resources, Inc. - Strategy, SWOT and Corporate Finance Report Summary Franklin Resources, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Fairfax Financial Holdings Limited:企業のM&A・事業提携・投資動向
    Fairfax Financial Holdings Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Fairfax Financial Holdings Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on m …
  • SGS SA (SGSN):石油・ガス:M&Aディール及び事業提携情報
    Summary SGS SA (SGS) is a provider of inspection, verification, testing, certification and quality assurance services. The company also provides risk management, consultancy, sustainability solutions and training services. SGS inspects, samples, analyzes, and monitors raw materials, components and p …
  • Volkswagen AG (VOW3):企業の財務・戦略的SWOT分析
    Volkswagen AG (VOW3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Verint Systems Inc. (VRNT):企業の財務・戦略的SWOT分析
    Verint Systems Inc. (VRNT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • TenCate Advanced Armour:企業の戦略・SWOT・財務情報
    TenCate Advanced Armour - Strategy, SWOT and Corporate Finance Report Summary TenCate Advanced Armour - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • The McClatchy Company:企業の戦略・SWOT・財務分析
    The McClatchy Company - Strategy, SWOT and Corporate Finance Report Summary The McClatchy Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Pronto Diagnostics Ltd-医療機器分野:企業M&A・提携分析
    Summary Pronto Diagnostics Ltd (PDL) is a medical device company that offers molecular diagnostic products and services. The company develops, produces and distributes SNP-detection kits providing assays for detecting polymorphisms in DNA sequences with genetic diseases and predisposition to disease …
  • Suburban Propane Partners LP (SPH):企業の財務・戦略的SWOT分析
    Summary Suburban Propane Partners LP (Suburban Propane) distributes and markets energy-related products. The company supplies propane, fuel oil and refined fuels, and markets natural gas and electricity in deregulated markets. Suburban Propane also provides installation and service of various types …
  • PBF Energy Inc. (PBF)-石油・ガス分野:企業M&A・提携分析
    Summary PBF Energy Inc. (PBF Energy) is an independent oil refining company. It owns and operates crude oil refineries and related facilities in the US. Its refining assets include Delaware City refinery, Delaware; Paulsboro refinery, New Jersey; Chalmette refinery, Louisiana, Torrance, California a …
  • Deoleo, S.A.:企業の戦略・SWOT・財務情報
    Deoleo, S.A. - Strategy, SWOT and Corporate Finance Report Summary Deoleo, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • OncoSec Medical Inc (ONCS)-製薬・医療分野:企業M&A・提携分析
    Summary OncoSec Medical Inc (OncoSec) is a biotechnology company that offers services to stimulate body’s immune system and attack cancer. It’s lead candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through i …
  • Shikoku Electric Power Co., Inc.:企業の戦略・SWOT・財務分析
    Shikoku Electric Power Co., Inc. - Strategy, SWOT and Corporate Finance Report Summary Shikoku Electric Power Co., Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Shanghai ChemPartner Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Shanghai ChemPartner Co Ltd (ChemPartner) is a life science contract research organization. The organization’s services include manufacturing of small molecules and biologics, drug discovery and development, biomarkers, preclinical and clinical sample bioanalysis, and analytical services, am …
  • Hatch Ltd:企業の戦略的SWOT分析
    Hatch Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Proteome Sciences Plc (PRM):企業の財務・戦略的SWOT分析
    Proteome Sciences Plc (PRM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆